HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A J M Boulton Selected Research

diazonaphthalenedisulfonic acid (NDS)

7/2009Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study.
5/2002A comparison of the Neuropen against standard quantitative sensory-threshold measures for assessing peripheral nerve function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A J M Boulton Research Topics

Disease

10Peripheral Nervous System Diseases (PNS Diseases)
01/2021 - 10/2002
7Diabetic Neuropathies (Diabetic Neuropathy)
12/2023 - 10/2002
5Type 2 Diabetes Mellitus (MODY)
01/2019 - 07/2009
5Diabetic Foot
01/2016 - 06/2002
4Pain (Aches)
01/2021 - 05/2002
4Wounds and Injuries (Trauma)
01/2016 - 06/2002
4Ulcer
10/2013 - 06/2002
3Foot Ulcer
01/2016 - 07/2002
2Glucose Intolerance
01/2017 - 01/2017
1Neuralgia (Stump Neuralgia)
12/2023
1Hypesthesia (Numbness)
01/2021
1Type I Syndactyly
01/2019
1Peripheral Arterial Disease
01/2016
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
10/2010
1Polyradiculoneuropathy (Polyradiculoneuritis)
07/2009
1Disease Progression
07/2005
1Hypoxia (Hypoxemia)
07/2005
1Diabetic Retinopathy (Retinopathy, Diabetic)
07/2005
1Hyperplasia
03/2005
1Foot Diseases
08/2004
1Polyuria
12/2002
1Diabetes Mellitus
12/2002
1Painful Neuropathy
10/2002
1Chronic Kidney Failure (Chronic Renal Failure)
08/2002
1Renal Insufficiency (Renal Failure)
08/2002
1Varicose Ulcer (Ulcer, Venous)
06/2002
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2002
1Atherosclerosis
04/2002

Drug/Important Bio-Agent (IBA)

8NAD (NADH)IBA
01/2021 - 07/2009
3Blood Glucose (Blood Sugar)IBA
07/2009 - 08/2002
2Vitamin DFDA LinkGeneric
01/2017 - 01/2017
2Oxygen (Dioxygen)IBA
01/2016 - 01/2010
2Indicators and Reagents (Reagents)IBA
05/2013 - 06/2008
2diazonaphthalenedisulfonic acid (NDS)IBA
07/2009 - 05/2002
2Biomarkers (Surrogate Marker)IBA
07/2005 - 12/2002
2Glucose (Dextrose)FDA LinkGeneric
10/2002 - 08/2002
1Antidepressive Agents (Antidepressants)IBA
12/2023
1Anticonvulsants (Antiepileptic Drugs)IBA
12/2023
1CholesterolIBA
01/2019
1DM 119IBA
01/2019
1A-factor (Streptomyces)IBA
01/2019
1Triglycerides (Triacylglycerol)IBA
01/2019
1MetalsIBA
10/2013
1Cholinergic Agents (Cholinergics)IBA
05/2013
1Arginine (L-Arginine)FDA Link
01/2010
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
07/2009
1Retinaldehyde (Retinal)IBA
07/2005
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
07/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2005
1Phenobarbital (Luminal)FDA Link
03/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2004
1Anti-Bacterial Agents (Antibiotics)IBA
11/2004
1Nylons (Nylon)IBA
08/2004
1Polyethylene Terephthalates (Polyethylene Terephthalate)IBA
08/2004
1SilverIBA
08/2004
1Transforming Growth Factor beta1 (TGF beta 1)IBA
06/2002
1Transforming Growth Factor beta3 (TGF beta 3)IBA
06/2002
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
06/2002
1Transforming Growth Factor beta (TGF-beta)IBA
06/2002
1Aryldialkylphosphatase (Paraoxonase)IBA
04/2002
1LDL Lipoproteins (beta Lipoproteins)IBA
04/2002
1oxidized low density lipoproteinIBA
04/2002

Therapy/Procedure

4Surgical Amputation (Amputations)
01/2016 - 07/2002
3Therapeutics
12/2023 - 05/2003
2Debridement
10/2013 - 11/2004
1Drug Therapy (Chemotherapy)
12/2023
1Spinal Cord Stimulation
12/2023
1Negative-Pressure Wound Therapy
01/2016
1Activities of Daily Living (ADL)
07/2009
1Transplantation
07/2009
1Artificial Skin
11/2004
1Electric Stimulation Therapy (Electrotherapy)
08/2004
1Electrodes (Electrode)
08/2004
1Continuous Ambulatory Peritoneal Dialysis (CAPD)
08/2002